NYKD.OL — Nykode Therapeutics

Health Care · Oslo Børs. Last price 3.44 NOK (+1.18% on the day). Raven's AI 12-month target for Nykode Therapeutics (5.50 NOK) is 12.0% below the analyst median (6.25 NOK, 2 analysts). Updated 2026-10-09.

Paper-trade Nykode Therapeutics free with 100 000 fake NOK and compete with other players on Raven Trading Game.

Raven’s AI view

Raven's AI sets a 12-month target of 5.50 NOK (+61.76% from 3.40 when it was set on 2026-10-09). Conviction: medium.

Catalysts: Phase 2/3 trial results; Partnership announcement

Risks: Trial failure; Financing dilution

Latest Nykode Therapeutics news

Oslo Børs announcements

Insider trades

Home · All Oslo Børs stocks · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot

More Health Care stocks: ABVX.PA Abivax · BIM.PA bioMérieux · CLARI.PA Clariane · DIM.PA Sartorius Stedim Biotech · EL.PA EssilorLuxottica · EMEIS.PA Emeis · ERF.PA Eurofins Scientific · GENT Gentian Diagnostics

RAVEN is taking longer than usual to load.
RELOAD